ETF · holdings as filed 2026-04-30
What's inside LABD?
Direxion Daily S&P Biotech Bear 3X Shares
- Holdings
- 5
- positions in the fund
- Expense ratio
- 1.07%
- net, per year
- Fund size
- $68M
- total net assets
Top 5 holdings
| Rank | Logo | Ticker / Name | Weight |
|---|
| 1 | ? | —GOLDMAN FINANCIAL | | 42.54% |
| 2 | ? | —DREYFUS GOVERNMENT CASH MANAGE | | 41.92% |
| 3 | ? | —GOLDMAN SACHS LIQ ES FD A | | 13.77% |
| 4 | ? | —DREYFUS | | 5.33% |
| 5 | ? | —N/A | | -3.56% |
Top holdings — Unresolved
Your 5 largest positions in this sector
1
?
—GOLDMAN FINANCIAL
42.54%2
?
—DREYFUS GOVERNMENT CASH MANAGE
41.92%3
?
—GOLDMAN SACHS LIQ ES FD A
13.77%Top holdings — Unresolved
Your 5 largest positions in this country
1
?
—GOLDMAN FINANCIAL
42.54%2
?
—DREYFUS GOVERNMENT CASH MANAGE
41.92%3
?
—GOLDMAN SACHS LIQ ES FD A
13.77%Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold LABD alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.